← Back to all signals
RESEARCH PAPER ANALYSIS

Development of a clinical decision support tool for Primary care Management of lower Urinary tract Symptoms in men: the PriMUS study.

AI interpretation is pending for this paper.

Open original publication →
PMID39895567
JournalHealth technology assessment (Winchester, England)
Publication Date2025-01-01
Ingested2026-08-02 12:03 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Lower urinary tract symptoms particularly affect older men and their quality of life. General practitioners currently have no easily available assessment tools to diagnose lower urinary tract symptom causes. Referrals to urology specialists are increasing. General practitioner access to simple, accurate tests and clinical decision tools could facilitate management of lower urinary tract symptoms in primary care. OBJECTIVES: To determine which of several index tests in combination, best predicted three diagnoses (detrusor overactivity, bladder outlet obstruction and/or detrusor underactivity) in men presenting with lower urinary tract symptoms in primary care. To develop and validate three diagnostic prediction models, and a prototype primary care clinical decision support tool. DESIGN: Prospective diagnostic accuracy study. Two participant cohorts, for development and validation, underwent simple index tests and a reference standard (invasive urodynamics). SETTING: General practices in England and Wales. PARTICIPANTS: Men (16 years and over) consulting their general practitioner with lower urinary tract symptoms. SAMPLE SIZE: Separate calculations for model development and validation cohorts, from literature estimates of detrusor overactivity, bladder outlet obstruction and detrusor underactivity prevalences of 57%, 31% and 16%, respectively. PREDICTORS AND INDEX TESTS: Twelve potential predictors considered for three diagnostic models. MAIN OUTCOME MEASURES: The primary outcome was diagnostic model sensitivity and specificity for detecting bladder outlet obstruction, detrusor underactivity and detrusor overactivity, with 75.0% considered minimum clinically useful performance. STATISTICAL ANALYSIS: Three separate logistic regression models generated with index test variables to predict the presence of bladder outlet obstruction, detrusor overactivity, detrusor underactivity conditions in men with lower urinary tract symptoms. RESULTS: One model each was developed and validated for bladder outlet obstruction and detrusor underactivity, two for detrusor overactivity (detrusor overactivity main, detrusor overactivity sensitivity analysis 2). Age, voiding symptoms subscore, prostate-specific antigen level, median maximum flow rate, median voided volume were predictors for bladder outlet obstruction. Median maximum flow rate and post-void residual volume were predictors for detrusor underactivity. Age, post-void residual volume and median voided volume were included in detrusor overactivity main model, while age and storage symptoms subscore predicted detrusor overactivity sensitivity analysis 2. For all four models, sensitivity of 75.0% could be achieved with a specificity of 74.2%, 47.3%, 45.6% and 46.2% for bladder outlet obstruction, detrusor underactivity, detrusor overactivity main and detrusor overactivity sensitivity analysis 2 models, respectively. Similarly, a specificity of 75.0% could be achieved with a sensitivity of 71.3%, 39.8%, 33.3% and 62.7% for bladder outlet obstruction, detrusor underactivity, detrusor overactivity main and detrusor overactivity sensitivity analysis 2 models, respectively. The prototype tool (not yet intended for use in practice) is available at Primary care Management of lower Urinary tract Symptoms decision aid for lower urinary tract symptoms (shinyapps.io). General practitioner feedback during tool development and small-scale user-testing in simulated consultation scenarios was favourable. Patients supported such management in primary care. STRENGTHS/LIMITATIONS: This was a prospective, multicentre study in an appropriate primary care population. Most of the index tests are possible routinely in primary care or at home by patients. The diagnostic models were validated in a separate cohort from the same population. Limitations include that target condition prevalences may differ in other populations. CONCLUSION: We identified sensitivities and specificities of diagnostic models for detrusor overactivity, bladder outlet obstruction and detrusor underactivity in routine United Kingdom practice and developed a prototype clinical decision support tool. FUTURE WORK: Economic modelling, a feasibility trial and powered randomised controlled trial are needed to evaluate the Primary care Management of lower Urinary tract Symptoms tool in practice. STUDY REGISTRATION: Current Controlled Trials ISRCTN10327305. FUNDING: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 15/40/05) and is published in full in Health Technology Assessment; Vol. 29, No. 1. See the NIHR Funding and Awards website for further award information.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 A Rare t(1;11)(q42;q23) Rearrangement with Trisomy 8 and Trisomy 21 in a Pediatric Acute Myeloid Leukemia Patient with Aberrant CD7 Expression and Jacob Syndrome: Diagnostic Value of Conventional Cytogenetics and Fluorescence in Situ Hybridization in a Rapidly Fatal Case. Journal of the Association of Genetic Technologists 56.0 2 A Highly Abnormal Clone in a Pediatric Patient with B-Lymphoblastic Leukemia. Journal of the Association of Genetic Technologists 47.5 3 Maternal polycystic ovary syndrome and the risk of neurodevelopmental disorders in preterm neonates. Pediatric endocrinology, diabetes, and metabolism 65.5 4 [Clinical analysis of 3 cases of childhood primary pure erythroid leukemia and literature review]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 64.4 5 [A retrospective analysis of clinicopathological features and efficacy in 51 patients with high-grade B-cell lymphoma with 11q abnormalities]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 72.1 6 [RET fusion-driven papillary thyroid cancer in children and adolescents: clinical characteristics, molecular mechanisms, and therapeutic advances]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 52.09 7 The diagnostic value of cyclin d1, EGFR, P53 and Ki-67 in epithelial dysplasi of the gallbladder. JPMA. The Journal of the Pakistan Medical Association 60.0 8 Increased brain cancer risk from constant mobile phone use in children. JPMA. The Journal of the Pakistan Medical Association 47.5 9 Pediatric Scurvy Presenting With Vertebral Insufficiency Fractures Mimicking Chronic Recurrent Multifocal Osteomyelitis in a Child With Autism Spectrum Disorder. Cureus 58.4 10 Behind the Curtain: A Pediatric Dermoid Tumor Masquerading as Craniopharyngioma. Cureus 56.0 11 Case Report: novel mutations in SMARCA4 cause Coffin-Siris syndrome type 4 with autism spectrum disorder without visual impairment in one patient. Frontiers in genetics 71.5 12 [Clinicopathological analysis of 18 cases of ovarian juvenile granulosa cell tumor]. Zhonghua fu chan ke za zhi 65.3 13 Efficacy and Safety of CAR-T Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia With Central Nervous System Involvement. Cancer medicine 76.66 14 Endothelial and Vascular Toxicity Signals Associated With Doxorubicin: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database. Pharmacoepidemiology and drug safety 67.34 15 Pediatric patients with cancer exhibit increased neutrophil extracellular traps and reduced active deoxyribonuclease I: diagnostic, prognostic, and therapeutic opportunities. Clinical and experimental pediatrics 73.44 16 Hepatocellular Carcinoma at a Center of Clinical Excellence in Colombia: A Real-World Cohort Study of Clinical Characteristics, Treatment Trajectories, and Survival. Journal of hepatocellular carcinoma 71.86 17 [Hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion in a childhood cancer survivor ‒ The role of oral urea in treatment]. Nutricion hospitalaria 59.54 18 NRF2 activation is required for chemotherapy resistance acquisition in medulloblastoma via metabolic and redox adaptation. Redox biology 62.94 19 Oncofertility care evaluation of 599 children and adolescents with cancer and a high risk of treatment-induced gonadal damage: a national paediatric oncology cohort study. Human reproduction (Oxford, England) 78.64 20 Epithelioid hemangioma from inferior turbinate in a pediatric patient: a case report. Journal of surgical case reports 45.5 21 Occupational Therapy Interventions for Pediatric Cancer: A Systematic Review and Meta-Analysis. Physical & occupational therapy in pediatrics 82.84 22 Ovarian Teratoma After Treatment for Coexisting Anti-NMDA Receptor and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalitis. Journal of child neurology 63.8 23 Insight into the Development of Desirable Dosage Forms and Bioenabling Strategies to Improve the Food Effect of Anticancer Drugs for the Pediatric Population. Molecular pharmaceutics 61.76 24 Evaluation of a Rapid Immunoassay for Molecular Subphenotype Classification in Pediatric Acute Cardiorespiratory Failure. Critical care medicine 69.6 25 "A dicey situation:" asymptomatic hypertensive urgency caused by DICER1 mutation-derived cystic nephroma in a 12-month-old. Pediatric nephrology (Berlin, Germany) 56.4 26 Distinct molecular profiles of indeterminate and malignant thyroid nodules in patients under 21 years of age. Endocrine-related cancer 64.5 27 Pediatric Myocarditis: Contemporary Insights Into Viral and Immune-Mediated Pathobiology, Precision Diagnostics, Advanced Multimodality Imaging, Risk Stratification, and Evolving Therapeutic Strategies. Cardiology in review 75.0 28 Clinical characteristics, prognosis, and achievement of transplant in adolescents and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in Argentina. Hematology, transfusion and cell therapy 71.8 29 "Like a Clinical Nurse Consultant in Your Pocket"-Parents' and Health Care Providers' Perceptions of a Co-Designed Smartphone App Following Treatment for Pediatric Cancer: Mixed Methods Evaluation Study. JMIR cancer 61.94 30 Management of Clostridioides difficile infections in patients with hematological malignancies - a survey by European Conference on Infections in Leukemia (ECIL) and Infectious Diseases Working Party (IDWP) of The European Society for Blood and Marrow Transplantation (EBMT). International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 63.6 31 Polycyclic aromatic hydrocarbon (PAH) levels in indoor air and their associated health risks for children across Europe. Environmental research 57.5 32 Utility and applications of high-field 1.5 T intraoperative magnetic resonance imaging in paediatric neurosurgery: a review of 5 years' experience. Neurocirugia 59.5
PATIENT-FRIENDLY SUMMARY

Development of a clinical decision support tool for Primary care Management of lower Urinary tract Symptoms in men: the PriMUS study.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic